Three AI Mega-Rounds Captured 89% of May's $31.6B VC Funding Wave

Three mega-rounds dominated May's venture capital market: Moonshot AI's unprecedented $20 billion valuation, Plug and Play Japan's $6.15 billion fund close, and Kimi's $2 billion Series C. These three deals alone captured $28.15 billion — or 89% of the $31.6 billion in total disclosed VC funding across 134 deals announced in the last 30 days.

The concentration is extraordinary. Venture capital in May was not a broad market participation story. It was a superpower play in artificial intelligence, with secondary bets on space technology and life sciences. Understanding what drove this concentration, and what it means for founders outside the AI core, is critical.

The Moonshot Moment: From Startup to $20 Billion in 18 Months

Moonshot AI's $20 billion valuation is not just a large round — it signals a fundamental shift in how the market values AI foundational model companies. The company, which was founded in late 2024, was valued at $20 billion less than 18 months later. That trajectory is not incremental. It is not a Series A or B getting a bump. It is a statement that the market believes a small number of AI startups can reach unicorn scale in months, not years.

This matters because it resets expectations. When Moonshot achieves a $20 billion valuation before a company has meaningful revenue, other AI companies pursuing similar technology bets immediately see a new ceiling for what's possible. Founders fundraising in June will cite this round. Investors will have to recalibrate their model assumptions about timelines, growth rates, and market size for AI model companies.

The speed is what makes May different. In previous eras, a company reaching $20 billion in valuation represented the pinnacle of venture success — the outcome you hoped for after a 7-10 year journey through Series A, B, C, D, and beyond. Moonshot reached that valuation in a sprint. For investors with FOMO, this was validation. For everyone else, it was a humbling reminder of how the rules have changed.

But Moonshot is not alone in this trajectory. Kimi, another AI model company, was reportedly near a $2 billion round at a $20+ billion valuation on the same dates. The pattern is not noise. The pattern is concentrated, repetitive validation of a single thesis: foundational AI model companies can reach massive valuations faster than any previous category in venture history. Astranis, the satellite communications company, shows the same phenomenon: the company raised $300 million at a strong valuation, then immediately raised another $450 million in a Series E. When you have momentum, the capital follows.

68% of May's Capital Went to AI

Across all 134 VC deals and 65 deals with disclosed sizes, artificial intelligence and machine learning absorbed $21.65 billion. That is 68% of May's total disclosed capital — a proportion that would have been unthinkable five years ago.

The remainder of venture capital was scattered across complementary and adjacent sectors. Satellite and space technology (Astranis raised $750 million across multiple tranches) is the second-largest segment. Biotech and life sciences (CellCentric's $220 million Series D, Anagram Therapeutics' $250 million round) raised $888 million collectively. Quantum computing (Quantum Motion raised $160 million for silicon-based quantum chips) and robotics (ROBOTERA raised $200 million to scale humanoid robot manufacturing) are emerging categories with meaningful capital flows, but still tiny relative to AI.

For investors tracking diversification, this concentration carries significant risk. If AI sentiment cools — due to market saturation, regulatory pressure, or empirical evidence that the ROI doesn't justify the valuations — the market contracts sharply. The diversification that traditionally protected venture capital — with strong performance in biotech one year, enterprise software the next, consumer internet another — is largely absent from May's numbers.

This trend accelerated throughout the month. On May 7th, when Moonshot's round was announced, 69 deals were disclosed (driven by news cycles around the mega-announcement). The proportion of AI deals spiked to 55% on that single day, though capital went even more heavily to AI due to the mega-round sizes.

Mega-Round Economics and the Seed Funding Crisis

The capital distribution by round size reveals a buried story in the May numbers. Just three mega-rounds (each over $2 billion) captured $28.15 billion. Meanwhile, 48 seed-stage companies raised only $686 million, an average of $14.3 million per deal.

This is not a healthy distribution. Venture capital is supposed to function as a pyramid: many small bets at seed and early Series A, progressively fewer but larger bets at Series B and C, and very rare mega-rounds reserved for proven winners. May's distribution is inverted — the mega-rounds and growth-stage rounds dwarf the entire early-stage segment.

Early-stage founders feel this inversion immediately. Seed capital is harder to raise when investors are fixated on the next $2 billion mega-deal. Diversity of thought is penalized. Startups pursuing incremental improvements or serving less sexy categories see funding windows close. The most well-capitalized seed firms (Sequoia, Andreessen Horowitz, Khosla Ventures) can write larger checks because they are raising larger funds, but the universe of accessible seed investors is contracting.

This creates a bifurcation in the startup ecosystem. On one side: AI companies, space startups, and quantum computing research efforts that can plausibly claim a path to massive scale. On the other side: nearly everything else. The median seed round of $14.3 million is insufficient for most non-AI categories to develop meaningful competitive advantages or prove business models at scale. Companies in healthcare IT, logistics, fintech, and other domains are forced to raise from angels, operator funds, or pre-venture capital investors before they can access institutional venture firms.

For founders not in AI, the May data is a warning label. The VCs chasing Moonshot-sized returns will not fund your Series A in customer analytics or logistics optimization. You need to find the subset of investors with a thesis aligned to your category, not chasing the AI megathread. This shift is already happening: we are seeing the emergence of category-focused funds (biotech, space, robotics, fintech) that operate independently of the mega-round phenomenon.

Investor Participation: Concentration Among Mega-VCs

Just as capital is concentrated in mega-rounds, investor participation in mega-rounds is concentrated among a small set of firms. Andreessen Horowitz appeared in 6 signals during May, Khosla Ventures in 3, and Thrive Capital in 2. These firms can write large checks because they have large funds and strong track records with previous mega-round winners. Smaller and emerging managers lack the firepower to participate in $2 billion rounds, further concentrating decision-making power among established players.

This concentration of investor power has downstream effects. New VC firms struggle to raise Fund II when mega-rounds are where the returns are. LPs (limited partners) want to back managers who can participate in the biggest opportunities. Emerging managers get pushed to smaller check sizes and earlier-stage companies, which is where the seed funding crisis intersects with investor consolidation.

Geography and Sector Patterns

AI and machine learning dominates absolutely at $21.65 billion. Space and satellite technology is a distant second at $750 million, driven largely by Astranis' mature Series E and E2. Biotech and life sciences raised $888 million across multiple deals (CellCentric, Anagram, and several European life science funds). Quantum and robotics are niche but growing, with quantum alone seeing $160 million raised.

Geographically, the US dominates VC announcements in the absolute numbers, though May saw notable funding from Japan (Plug and Play's $6.15 billion yen-denominated fund), the UK (Quantum Motion, Corgi AI insurance), and across continental Europe. The headline mega-rounds — especially Moonshot and Kimi — are centered in Silicon Valley and China's AI startup ecosystem, reflecting the geographic concentration of both AI talent and capital.

This geographic pattern is stable. US-based AI companies attract global capital. European startups in quantum and space technology attract US investors seeking exposure to non-US teams. But the flow is heavily one-directional: American and Chinese capital is seeking the world's best AI talent, wherever it is.

What May's Data Means for the Broader Market

May's VC market is not a steady-state equilibrium. It is a peak. When 89% of disclosed capital is captured by three deals, reversion is inevitable. The question is not whether the concentration will normalize, but how and when.

Three scenarios are plausible:

Scenario 1: Continuation. Moonshot's valuation validates the entire mega-round thesis. Investors raise larger funds, mega-rounds become routine, and the median deal size creeps upward. In this case, seed-stage funding starves further, and only the most capital-efficient early-stage plays survive. This is the venture equivalent of a "winner-take-all" market, where power and capital concentrate at the top.

Scenario 2: Reversion. June brings a pullback. AI sentiment cools slightly due to market saturation or valuation concerns. Mega-rounds become rarer, but the capital deployed is more distributed across Series A through D rounds. Seed funding normalizes, and the investment pyramid restores a healthier shape.

Scenario 3: Bifurcation. The mega-round phenomenon becomes a permanent feature, but only for approved categories (AI models, certain enterprise applications, space tech). Everything else exists in a parallel, smaller market with lower multiples and longer fundraising cycles. This is the most likely outcome based on historical precedent. We saw this with mobile (mega-rounds for Uber, Airbnb, Instagram; everything else struggled) and in crypto (mega-rounds for Blockchain companies; traditional fintech got starved out).

For investors and founders, the data point from May is clear: concentration in VC is at historic levels. Moonshot AI's $20 billion valuation is not an outlier. It is the peak of a trend toward consolidation of capital into fewer, larger bets on a smaller number of companies. Managing that concentration — through fund strategy, portfolio construction, and founder preparedness — will define the next chapter of venture capital.